Detalhe da pesquisa
1.
Evaluation of systemic absorption and bronchodilator effect of glycopyrronium bromide delivered by nebulizer or a dry powder inhaler in subjects with chronic obstructive pulmonary disease.
Respir Res
; 20(1): 132, 2019 Jun 28.
Artigo
Inglês
| MEDLINE | ID: mdl-31253162
2.
Effect of smoking status on lung function, patient-reported outcomes, and safety among COPD patients treated with glycopyrrolate inhalation powder: pooled analysis of GEM1 and GEM2 studies.
Respir Res
; 20(1): 135, 2019 Jul 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31266489
3.
Efficacy of Indacaterol/Glycopyrrolate in Patients with COPD by Airway Reversibility at Baseline: A Pooled Analysis of the FLIGHT1 and FLIGHT2 12-Week Studies.
COPD
; 16(2): 133-139, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31242792
4.
Phase 3 Study of Subcutaneous Versus Intravenous Ravulizumab in Eculizumab-Experienced Adult Patients with PNH: Primary Analysis and 1-Year Follow-Up.
Adv Ther
; 40(1): 211-232, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36272026
5.
Effect of SGRQ-Defined Chronic Bronchitis at Baseline on Treatment Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate.
Int J Chron Obstruct Pulmon Dis
; 16: 945-955, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33880019
6.
Impact of Comorbidity Prevalence and Cardiovascular Disease Status on the Efficacy and Safety of Nebulized Glycopyrrolate in Patients with COPD.
Int J Chron Obstruct Pulmon Dis
; 16: 1061-1073, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33907393
7.
Improvement in Lung Function and Patient-Reported Outcomes in Patients with COPD with Comorbid Anxiety and Depression Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies.
Int J Chron Obstruct Pulmon Dis
; 16: 865-875, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33833507
8.
Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate.
Int J Chron Obstruct Pulmon Dis
; 15: 995-1004, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32440111
9.
The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies.
Int J Chron Obstruct Pulmon Dis
; 15: 745-754, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32341641
10.
The Effect of Metabolic Syndrome Status on Lung Function and Patient-reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate.
Chronic Obstr Pulm Dis
; 7(4): 315-326, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-32822528
11.
On the use of nonparametric tests for comparing immunological Reverse Cumulative distribution curves (RCDCs).
Vaccine
; 37(44): 6737-6742, 2019 10 16.
Artigo
Inglês
| MEDLINE | ID: mdl-31537446
12.
Satisfaction with the Use of eFlow Closed-System Nebulizer in Patients with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease: Findings from a Long-Term Safety Study.
J Aerosol Med Pulm Drug Deliv
; 32(1): 24-33, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30457433
13.
Effect of smoking status on lung function, patient-reported outcomes, and safety among patients with COPD treated with indacaterol/glycopyrrolate: Pooled analysis of the FLIGHT1 and FLIGHT2 studies.
Respir Med
; 155: 113-120, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31344660
14.
Efficacy and safety of glycopyrrolate in patients with COPD by reversibility: pooled analysis of GEM1 and GEM2 12-week studies.
Int J Chron Obstruct Pulmon Dis
; 14: 461-470, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-30863047
15.
Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial.
Vaccine
; 34(19): 2170-8, 2016 Apr 27.
Artigo
Inglês
| MEDLINE | ID: mdl-27013431
16.
Response letter to Dr. Blackwelder and Dr. Reed's letter regarding "On the use of nonparametric tests for comparing immunological reverse cumulative distribution curves (RCDCs)".
Vaccine
; 38(25): 4058, 2020 05 22.
Artigo
Inglês
| MEDLINE | ID: mdl-32389328
17.
Safety and immunogenicity of a quadrivalent intradermal influenza vaccine in adults.
Vaccine
; 33(9): 1151-9, 2015 Feb 25.
Artigo
Inglês
| MEDLINE | ID: mdl-25613721
18.
Immunogenicity and safety of Fluzone(®) intradermal and high-dose influenza vaccines in older adults ≥65 years of age: a randomized, controlled, phase II trial.
Vaccine
; 32(21): 2507-17, 2014 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-24120672
19.
Safety and immunogenicity of revaccination with reduced dose intradermal and standard dose intramuscular influenza vaccines in adults 18-64 years of age.
Vaccine
; 31(50): 6034-40, 2013 Dec 05.
Artigo
Inglês
| MEDLINE | ID: mdl-24055306